Biologically Active Small Molecules

13,14-dihydro-15-keto Prostaglandin D2-d4 (13,14-dihydro-15-keto PGD2-d4) contains four deuterium atoms at the 3, 3&#39, 4, and 4&#39 positions. It is intended for use as an internal standard for the quantification of 13,14-dihydro-15-keto PGD2 by

A metabolite of PGE1 with significantly reduced biological activity.

A metabolite of PGE1 with significantly reduced biological activity.

A metabolite of PGE1 with significantly reduced biological activity.

13,14-dh-15-k PGE1-d4 contains four deuterium atoms at the 3, 3&#39, 4, and 4&#39 positions. It is intended for use as an internal standard for the quantification of 13,14-dh-15-k PGE1 by GC- or LC-mass spectrometry.

13,14-dh-15-k PGE1-d4 contains four deuterium atoms at the 3, 3&#39, 4, and 4&#39 positions. It is intended for use as an internal standard for the quantification of 13,14-dh-15-k PGE1 by GC- or LC-mass spectrometry.

13,14-dh-15-k PGE1-d4 contains four deuterium atoms at the 3, 3&#39, 4, and 4&#39 positions. It is intended for use as an internal standard for the quantification of 13,14-dh-15-k PGE1 by GC- or LC-mass spectrometry.

The primary metabolite of PGE2 in plasma which is formed through the 15-hydroxy PGDH pathway.

The primary metabolite of PGE2 in plasma which is formed through the 15-hydroxy PGDH pathway.

The primary metabolite of PGE2 in plasma which is formed through the 15-hydroxy PGDH pathway.

An internal standard for the quantification of 13,14-dihydro-15-keto PGE2 by GC- or LC-MS.

An internal standard for the quantification of 13,14-dihydro-15-keto PGE2 by GC- or LC-MS.